SK Plasma has signed an MOU with Indonesia's sovereign wealth fund Danantara to invest in blood product manufacturing infrastructure, aiming to reduce import dependence and strengthen Indonesia's healthcare system.
#YonhapInfomax #SKPlasma #Danantara #BloodProducts #IndonesiaInvestmentAuthority #HealthcareInfrastructure #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=89991
SK Plasma Partners with Indonesia's Sovereign Wealth Fund Danantara for Blood Product Investment
SK Plasma has signed an MOU with Indonesia's sovereign wealth fund Danantara to invest in blood product manufacturing infrastructure, aiming to reduce import dependence and strengthen Indonesia's healthcare system.
SK Plasma Co. signed a 12 billion won ($8.7 million) investment MOU with Andong City to expand plasma storage and production infrastructure, aiming to stabilize blood product supply and boost the regional bio industry.
#YonhapInfomax #SKPlasma #AndongCity #PlasmaFractionation #InvestmentMOU #BloodProducts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=72078
SK Plasma Signs 12 Billion Won Investment MOU with Andong City to Expand Plasma Fractionation Infrastructure
SK Plasma Co. signed a 12 billion won ($8.7 million) investment MOU with Andong City to expand plasma storage and production infrastructure, aiming to stabilize blood product supply and boost the regional bio industry.
NICE Investors Service has assigned an inaugural 'A+' credit rating to GC Holdings, citing strong business fundamentals, stable cash flows, and growth prospects in blood products, while noting potential investment burdens and affiliate funding risks.
#YonhapInfomax #GCHoldings #NICEInvestorsService #CreditRating #BloodProducts #InvestmentRisks #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=66718
NICE Investors Service Assigns 'A+' Credit Rating to GC Holdings, Citing Strong Business Fundamentals
NICE Investors Service has assigned an inaugural 'A+' credit rating to GC Holdings, citing strong business fundamentals, stable cash flows, and growth prospects in blood products, while noting potential investment burdens and affiliate funding risks.
GC Green Cross Expected to Turn Profitable in Q1 - 'Subsidiaries Still Struggling'
GC Green Cross expected to turn profitable in Q1 2025, driven by blood product price hikes and vaccine exports, while subsidiaries continue to struggle with losses
Yonhap Infomax News